Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|September 11, 2024
Neuroendocrine differentiation (ND) in sensitivity of neuroendocrine tumor (NET) cells to ONC201/TIC10 cancer therapeuticElizabeth Ding, Maximillian Pinho-Schwermann, Shengliang Zhang, et al.
Frontiers in Oncology|December 19, 2024
Targeting the SMURF2-HIF1α axis: a new frontier in cancer therapyEmile Youssef, Shuai Zhao, Connor Purcell, et al.
American Journal of Translational Research|February 17, 2025
Small cell lung cancer and prostate cancer cells with varying neuroendocrine differentiation markers show sensitivity to imipridone ONC201/TIC10Elizabeth Ding, Maximillian Pinho-Schwermann, Shengliang Zhang, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell LinesConnor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
American Journal of Translational Research|January 17, 2025
Neuroendocrine prostate cancer drivers SOX2 and BRN2 confer differential responses to imipridones ONC201, ONC206, and ONC212 in prostate cancer cell linesConnor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Cancers|February 13, 2025
Heterogeneity in CancerWilliam J MacDonald, Connor Purcell, Maximilian Pinho-Schwermann, et al.
American Journal of Cancer Research|January 12, 2026
Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinomaWilliam J MacDonald, Praveen R Srinivasan, Maximilian Pinho-Schwermann, et al.
Oncotarget|March 13, 2025
Signaling pathway dysregulation in breast cancerDinara Ryspayeva, Attila A Seyhan, William J MacDonald, et al.
Cancer Letters|May 23, 2026
Biomarker-Guided Strategies for Tumor Vasculature: From Imaging Advances to Novel Therapeutic InterventionsConnor Purcell, Dinara Ryspayeva, Jay Gopal, et al.
Cancer Cell|September 23, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, Tetsuo Tani, Benjamin F Springer, et al.
Pageof 2